Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate. (Q53082999)
Jump to navigation
Jump to search
scientific article published on 16 January 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate. |
scientific article published on 16 January 2014 |
Statements
Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate. (English)
Samer Ezziddin
Mared Attassi
Charlotte J Yong-Hing
Winfried Willinek
Frank Grünwald
Stefan Guhlke
Hans-Jürgen Biersack
Amir Sabet
16 January 2014
55
2
183-190